Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heteroaryl compounds as BTK inhibitors and uses thereof

Heteroaryl compounds as BTK inhibitors and uses thereof

US Patent 10329270 · Granted Jun 25, 2019

Estimated economic value: $97,538,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fused imidazopyridines as reversible inhibitors of Brutons Tyrosine Kinase (BTK)2025
Fused imidazopyridines as reversible inhibitors of Brutons Tyrosine Kinase (BTK)2025
Fused imidazopyridines as reversible inhibitors of Brutons Tyrosine Kinase (BTK)2025
Fused imidazopyridines as reversible inhibitors of Brutons Tyrosine Kinase (BTK)2025
Fused imidazopyridines as reversible inhibitors of Brutons Tyrosine Kinase (BTK)2025
KRAS G12D proteolysis targeting chimeras2025
Modulators of TREX12024
Compounds and uses thereof2024
GCN2 inhibitors and uses thereof2024
GCN2 inhibitors and uses thereof2024
Substituted pyrazoles as type II IRAK inhibitors2024
Pyrimidinone derivatives as SHP2 antagonists2023